Albendazole - Revision history

Danbot: Restore original dosing content alongside dynamic SMW tables

2026-03-20T02:39:13Z

Restore original dosing content alongside dynamic SMW tables

← Older revision		Revision as of 02:39, 20 March 2026
Line 5:		Line 5:

	==Adult Dosing==		==Adult Dosing==
			*Microsporidiosis: 400mg po bid
			*neurocysticerosis: < 60 kg: 15mg/kg/day PO BID x 8-30 days, max 800mg/day. >60 kg: 400mg PO BID x 8-30 days


	===Indications by Disease===		===Indications by Disease===
	{{#ask: [[Has DrugName::Albendazole]] [[Has Population::Adult]]		{{#ask: [[Has DrugName::Albendazole]] [[Has Population::Adult]]
	\|?Treats disease=Disease		\|?Treats disease=Disease
	\|?Has Dose=Dose		\|?Has Dose=Dose
	\|?Has Context=Context		\|?Has Context=Context
	\|format=table		\|format=table
	\|limit=50		\|limit=50
	\|mainlabel=-		\|mainlabel=-
	\|headers=show		\|headers=show
	\|sort=Treats disease		\|sort=Treats disease
	}}		}}

	==Pediatric Dosing==		==Pediatric Dosing==
			*neurocysticerosis: < 60 kg: 15mg/kg/day PO BID x 8-30 days, max 800mg/day. >60 kg: 400mg PO BID x 8-30 days


	===Indications by Disease===		===Indications by Disease===
	{{#ask: [[Has DrugName::Albendazole]] [[Has Population::Pediatric]]		{{#ask: [[Has DrugName::Albendazole]] [[Has Population::Pediatric]]
	\|?Treats disease=Disease		\|?Treats disease=Disease
	\|?Has Dose=Dose		\|?Has Dose=Dose
	\|?Has Context=Context		\|?Has Context=Context
	\|format=table		\|format=table
	\|limit=50		\|limit=50
	\|mainlabel=-		\|mainlabel=-
	\|headers=show		\|headers=show
	\|sort=Treats disease		\|sort=Treats disease
	}}		}}

2026-03-20T01:53:46Z

Replace manual dosing with dynamic SMW tables (Adult + Pediatric)

← Older revision		Revision as of 01:53, 20 March 2026
Line 5:		Line 5:

	==Adult Dosing==		==Adult Dosing==
	*Microsporidiosis: ~~400mg po bid~~		===Indications by Disease===
	*neurocysticerosis: ~~< 60 kg~~: ~~15mg/kg/day PO BID x 8-30 days, max 800mg/day. >60 kg~~: ~~400mg PO BID x 8~~-~~30 days~~		{{#ask: [[Has DrugName::Albendazole]] [[Has Population::Adult]]
			\|?Treats disease=Disease
			\|?Has Dose=Dose
			\|?Has Context=Context
			\|format=table
			\|limit=50
			\|mainlabel=-
			\|headers=show
			\|sort=Treats disease
			}}

	==Pediatric Dosing==		==Pediatric Dosing==
	*neurocysticerosis: ~~< 60 kg~~: ~~15mg/kg/day PO BID x 8-30 days, max 800mg/day. >60 kg~~: ~~400mg PO BID x 8~~-~~30 days~~		===Indications by Disease===
			{{#ask: [[Has DrugName::Albendazole]] [[Has Population::Pediatric]]
			\|?Treats disease=Disease
			\|?Has Dose=Dose
			\|?Has Context=Context
			\|format=table
			\|limit=50
			\|mainlabel=-
			\|headers=show
			\|sort=Treats disease
			}}

	==Special Populations==		==Special Populations==

2019-09-19T16:39:11Z

← Older revision		Revision as of 16:39, 19 September 2019
Line 52:		Line 52:
	<references/>		<references/>

	[[Category:Pharmacology]]		[[Category:Pharmacology]] [[Category:ID]]

2019-06-06T15:59:33Z

General

← Older revision		Revision as of 15:59, 6 June 2019
Line 1:		Line 1:
	==General==		==General==
	*Type: [[Antiparasitic]]		*Type: [[Antiparasitic]]/Antihelmintic
	*Dosage Forms: 200mg		*Dosage Forms: 200mg
	*Common Trade Names:Albenza		*Common Trade Names:Albenza

2017-07-13T06:25:23Z

2017-03-28T17:56:50Z

General

2016-07-19T03:28:02Z

Text replacement - "5 mg" to "5mg"

← Older revision		Revision as of 03:28, 19 July 2016
Line 6:		Line 6:
	==Adult Dosing==		==Adult Dosing==
	*Microsporidiosis: 400mg po bid		*Microsporidiosis: 400mg po bid
	*neurocysticerosis: < 60 kg: ~~15 mg~~/kg/day PO BID x 8-30 days, max 800mg/day. >60 kg: 400mg PO BID x 8-30 days		*neurocysticerosis: < 60 kg: 15mg/kg/day PO BID x 8-30 days, max 800mg/day. >60 kg: 400mg PO BID x 8-30 days

	==Pediatric Dosing==		==Pediatric Dosing==
	*neurocysticerosis: < 60 kg: ~~15 mg~~/kg/day PO BID x 8-30 days, max 800mg/day. >60 kg: 400mg PO BID x 8-30 days		*neurocysticerosis: < 60 kg: 15mg/kg/day PO BID x 8-30 days, max 800mg/day. >60 kg: 400mg PO BID x 8-30 days

	==Special Populations==		==Special Populations==

2016-07-19T03:12:31Z

Text replacement - "0 mg" to "0mg"

← Older revision		Revision as of 03:12, 19 July 2016
Line 1:		Line 1:
	==General==		==General==
	*Type: antiparasitic		*Type: antiparasitic
	*Dosage Forms: ~~200 mg~~		*Dosage Forms: 200mg
	*Common Trade Names:Albenza		*Common Trade Names:Albenza

	==Adult Dosing==		==Adult Dosing==
	*Microsporidiosis: ~~400 mg~~ po bid		*Microsporidiosis: 400mg po bid
	*neurocysticerosis: < 60 kg: 15 mg/kg/day PO BID x 8-30 days, max ~~800 mg~~/day. >60 kg: ~~400 mg~~ PO BID x 8-30 days		*neurocysticerosis: < 60 kg: 15 mg/kg/day PO BID x 8-30 days, max 800mg/day. >60 kg: 400mg PO BID x 8-30 days

	==Pediatric Dosing==		==Pediatric Dosing==
	*neurocysticerosis: < 60 kg: 15 mg/kg/day PO BID x 8-30 days, max ~~800 mg~~/day. >60 kg: ~~400 mg~~ PO BID x 8-30 days		*neurocysticerosis: < 60 kg: 15 mg/kg/day PO BID x 8-30 days, max 800mg/day. >60 kg: 400mg PO BID x 8-30 days

	==Special Populations==		==Special Populations==

2016-06-26T12:46:18Z

Text replacement - "==Sources==" to "==References=="

2016-03-22T15:54:05Z

Text replacement - "Category:Drugs" to "Category:Pharmacology"